miR-200a-3p overexpression alleviates diabetic cardiomyopathy injury in mice by regulating autophagy through the FOXO3/Mst1/Sirt3/AMPK axis.

Autor:	You P; Department of Cardiology, Shaanxi Provincial People's Hospital, Xi'an, China., Chen H; Department of Cardiology, Shaanxi Provincial People's Hospital, Xi'an, China., Han W; Department of Cardiology, Shaanxi Provincial People's Hospital, Xi'an, China., Deng J; Department of Cardiology, Shaanxi Provincial People's Hospital, Xi'an, China.
Jazyk:	angličtina
Zdroj:	PeerJ [PeerJ] 2023 Sep 15; Vol. 11, pp. e15840. Date of Electronic Publication: 2023 Sep 15 (Print Publication: 2023).
DOI:	10.7717/peerj.15840
Abstrakt:	Objective: Hyperglycemia and insulin resistance or deficiency are characteristic features of diabetes. Diabetes is accompanied by cardiomyocyte hypertrophy, fibrosis and ventricular remodeling, and eventually heart failure. In this study, we established a diabetic cardiomyopathy (DCM) mouse model to explore the role and mechanism of miR-200a-3p in DCM. Methods: We used db/db mice to simulate the animal model of DCM and the expression of miR-200a-3p was then examined by RT-qPCR. Tail vein injection of mice was done with rAAV-miR-200a-3p for 8 weeks, and cardiac function was assessed by cardiac ultrasound. The levels of myocardial tissue injury, fibrosis, inflammation, apoptosis and autophagy in mice were detected by histological staining, TUNEL and other molecular biological experiments. Results: miR-200a-3p expression levels were significantly decreased in the myocardium of DCM mice. Diabetic mice developed cardiac dysfunction and presented pathological changes such as myocardial injury, myocardial interstitial fibrosis, cardiomyocyte apoptosis, autophagy, and inflammation. Overexpression of miR-200a-3p expression significantly ameliorated diabetes induced-cardiac dysfunction and myocardial injury, myocardial interstitial fibrosis, cardiomyocyte apoptosis, and inflammation, and enhanced autophagy. Mechanistically, miR-200a-3p interacted with FOXO3 to promote Mst1 expression and reduce Sirt3 and p-AMPK expression. Conclusion: In type 2 diabetes, increased miR-200a-3p expression enhanced autophagy and participated in the pathogenic process of cardiomyopathy throug7 Mst1/Sirt3/AMPK axis regulation by its target gene FOXO3. This conclusion provides clues for the search of new gene targeted therapeutic approaches for diabetic cardiomyopathy. Competing Interests: The authors declare that they have no competing interests. (© 2023 You et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu